HCW Biologics is trading 5.19% up at $4.66 today amid post-split trading dynamics and broader market gains.

  • The stock's 1-for-6 reverse split became effective on June 30, 2026.
  • No major company-specific announcements were found for July 09, 2026, suggesting the move is tied to general market momentum.
  • The broader market is showing strength, with the S&P 500 up 0.58% and the Nasdaq up 0.60%.